Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Controlled drugs

Anaesthesiologists call on UN to resist making ketamine a controlled substance

The World Federation of Societies of Anaesthesiologists (WFSA) has called for support to protect the status of the anaesthetic ketamine as an essential medicine. 

The plea comes in response to repeated attempts by China and other south-east Asian countries that have problems with ketamine abuse in the general population to have the drug listed on the United Nation’s schedule of controlled drugs. 

But campaigners, including the WFSA, say that this would be disastrous in low and middle-income countries such as those in Africa and Asia where ketamine is often the only available anaesthetic. They also point out that the drug is widely used in caesarean sections and trauma surgeries and, as it is injectable, can be easily transported and stored in disaster areas and war zones. 

The WFSA says that ketamine has been reviewed several times since 2004, when attention to illicit use was first drawn by the International Narcotics Control Board. However, the World Health Organization has consistently said that on the balance of evidence, restrictions to medical access would be harmful to public health. 

China tried to have ketamine scheduled as a controlled substance at the UN Commission on Narcotic Drugs in March 2015 and the matter was raised again at this year’s meeting in March 2016. The WFSA says that although these attempts have been unsuccessful so far, there is concern that China will continue to return to the issue. 

Speaking at the World Congress of Anaesthesiologists in Hong Kong 28th August-2nd September 2016, WFSA president-elect Jannicke Mellin-Olsen, said: “We call on the UN’s Expert Committee on Drug Dependence not to recommend any further restrictions on ketamine pending the collection of more reliable and complete data on the effects that this might have on the availability of this essential anaesthetic drug, and on patient outcomes around the world.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201661

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Handbook of Drug Administration via Enteral Feeding Tubes

    Handbook of Drug Administration via Enteral Feeding Tubes

    All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.

    £54.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Making Medicines

    Making Medicines

    An illustrated history of therapeutics and pharmacy, from the Egyptians through to the present day.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • A vial of ketamine

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.